Patient preferences regarding intraoperative versus external beam radiotherapy for early breast cancer and the impact of socio-demographic factors
- 22 Downloads
Patient comfort and preference have steadily gained attention in radio-oncologic treatment of breast cancer. Therefore, the purpose of this investigation was to further explore patient preferences in choosing between intraoperative radiotherapy (IORT) and external beam radiotherapy (EBRT).
We prospectively analysed data of 101 women, who were candidates for breast-conserving surgery with adjuvant radiotherapy. A two-part video was shown to patients: an educational section about EBRT/IORT, followed by a preference elicitation section focusing on additional accepted risk (AAR) of recurrence after either treatment. Furthermore, participants completed a questionnaire to identify factors that influence patient preference of radiation modality.
The data demonstrate that 42.5% of patients would accept additional risk of recurrence for IORT versus 9% AAR for EBRT, while 48.5% of patients would not accept any additional risk, yet would choose IORT over EBRT if risks of recurrence were equivalent. When combining patient preferences and the results from the questionnaire, no single socio-economic/-demographic factor was found to significantly correlate with AAR of IORT.
Our study confirms the existence of subgroups of breast cancer patients who would accept an additional risk of recurrence associated with choice of radiation modality to receive a single dose of IORT as adjuvant radiotherapy for breast cancer instead of EBRT over several weeks; yet our data fail to identify a single factor significantly associated with these patient preferences and, therefore, helpful for individualised decision-making processes.
KeywordsIntraoperative radiotherapy (IORT) Breast cancer Breast-conserving surgery Patient preference External beam whole breast radiotherapy (EBRT) Shared decision-making
List of Abbreviations
Additional accepted risk
External beam whole breast radiotherapy
SS: project development, data management, data analysis, provision of study patients, manuscript writing, final approval of manuscript. SK: data collection, data analysis, provision of study patients, final approval of manuscript. SH: data analysis, final approval of manuscript. FW: project development, administrative support, provision of study patients, final approval of manuscript. AG: project development, data analysis, administrative support, provision of study patients, final approval of manuscript. MS: project development, data analysis, administrative support, provision of study patients, final approval of manuscript, supervision.
Compliance with ethical standards
Conflict of interest
Carl Zeiss Meditec supports radiobiological research in the Department of Radiation Oncology (Frederik Wenz). Marc Sütterlin reports reception of lecture fees in regard to IORT. The remaining authors declare that they have no competing interests.
All patients provided informed consent.
The ethical approval for this study was obtained through Ethics Committee II, Heidelberg University, Medical Faculty Mannheim (2013-591N-MA).
- 1.Tuschy B, Berlit S, Romero S, Sperk E, Wenz F, Kehl S, Sutterlin M (2013) Clinical aspects of intraoperative radiotherapy in early breast cancer: short-term complications after IORT in women treated with low energy X-rays. Radiat oncol 8:95. https://doi.org/10.1186/1748-717X-8-95 CrossRefPubMedPubMedCentralGoogle Scholar
- 5.Blank E, Kraus-Tiefenbacher U, Welzel G, Keller A, Bohrer M, Sutterlin M, Wenz F (2010) Single-center long-term follow-up after intraoperative radiotherapy as a boost during breast-conserving surgery using low-kilovoltage X-rays. Ann Surg Oncol 17(Suppl 3):352–358. https://doi.org/10.1245/s10434-010-1265-z CrossRefPubMedGoogle Scholar
- 6.Vaidya JS, Joseph DJ, Tobias JS, Bulsara M, Wenz F, Saunders C, Alvarado M, Flyger HL, Massarut S, Eiermann W, Keshtgar M, Dewar J, Kraus-Tiefenbacher U, Sutterlin M, Esserman L, Holtveg HM, Roncadin M, Pigorsch S, Metaxas M, Falzon M, Matthews A, Corica T, Williams NR, Baum M (2010) Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial. Lancet 376(9735):91–102. https://doi.org/10.1016/S0140-6736(10)60837-9 CrossRefPubMedGoogle Scholar
- 7.Wenz F, Welzel G, Blank E, Hermann B, Steil V, Sutterlin M, Kraus-Tiefenbacher U (2010) Intraoperative radiotherapy as a boost during breast-conserving surgery using low-kilovoltage X-rays: the first 5 years of experience with a novel approach. Int J Radiat Oncol Biol Phys 77(5):1309–1314. https://doi.org/10.1016/j.ijrobp.2009.06.085 CrossRefPubMedGoogle Scholar
- 10.Alvarado MD, Conolly J, Park C, Sakata T, Mohan AJ, Harrison BL, Hayes M, Esserman LJ, Ozanne EM (2014) Patient preferences regarding intraoperative versus external beam radiotherapy following breast-conserving surgery. Breast Cancer Res Treat 143(1):135–140. https://doi.org/10.1007/s10549-013-2782-9 CrossRefPubMedGoogle Scholar
- 12.Palda VA, Llewellyn-Thomas HA, Mackenzie RG, Pritchard KI, Naylor CD (1997) Breast cancer patients’ attitudes about rationing postlumpectomy radiation therapy: applicability of trade-off methods to policy-making. J Clin Oncol 15(10):3192–3200. https://doi.org/10.1200/JCO.1922.214.171.12492 CrossRefPubMedGoogle Scholar
- 13.Brown SM, Culver JO, Osann KE, MacDonald DJ, Sand S, Thornton AA, Grant M, Bowen DJ, Metcalfe KA, Burke HB, Robson ME, Friedman S, Weitzel JN (2011) Health literacy, numeracy, and interpretation of graphical breast cancer risk estimates. Patient Educ Couns 83(1):92–98. https://doi.org/10.1016/j.pec.2010.04.027 CrossRefPubMedPubMedCentralGoogle Scholar
- 15.Sperk E, Welzel G, Keller A, Kraus-Tiefenbacher U, Gerhardt A, Sutterlin M, Wenz F (2012) Late radiation toxicity after intraoperative radiotherapy (IORT) for breast cancer: results from the randomized phase III trial TARGIT A. Breast Cancer Res Treat 135(1):253–260. https://doi.org/10.1007/s10549-012-2168-4 CrossRefPubMedGoogle Scholar
- 17.Mussari S, Sabino Della Sala W, Busana L, Vanoni V, Eccher C, Zani B, Menegotti L, Tomio L (2006) Full-dose intraoperative radiotherapy with electrons in breast cancer. First report on late toxicity and cosmetic results from a single-institution experience. Strahlenther Onkol 182(10):589–595. https://doi.org/10.1007/s00066-006-1559-z CrossRefPubMedGoogle Scholar
- 18.Fastner G, Sedlmayer F, Merz F, Deutschmann H, Reitsamer R, Menzel C, Stierle C, Farmini A, Fischer T, Ciabattoni A, Mirri A, Hager E, Reinartz G, Lemanski C, Orecchia R, Valentini V (2013) IORT with electrons as boost strategy during breast conserving therapy in limited stage breast cancer: long term results of an ISIORT pooled analysis. Radiother Oncol 108(2):279–286. https://doi.org/10.1016/j.radonc.2013.05.031 CrossRefPubMedGoogle Scholar
- 22.Hamelinck VC, Bastiaannet E, Pieterse AH, Jannink I, van de Velde CJ, Liefers GJ, Stiggelbout AM (2014) Patients’ preferences for surgical and adjuvant systemic treatment in early breast cancer: a systematic review. Cancer Treat Rev 40(8):1005–1018. https://doi.org/10.1016/j.ctrv.2014.06.007 CrossRefPubMedGoogle Scholar